Wendell Guerra

Dr. Wendell Guerra

Instituto de Química, Universidade Federal de Uberlândia, Campus Santa Mônica, Uberlândia 38400-902, MG, Brazil

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 June 2011 in Inorganic Chemistry
Verified
Journal Article
Closed access
PSPriscila Silva-Caldeira
Priscila Silva-Caldeira
WGWendell Guerra
Wendell Guerra
JSJosiane N. Silveira
Josiane N. Silveira
Ana Maria Da Costa FerreiraAna Maria Da Costa Ferreira
Ana Maria Da Costa Ferreira
TBTiago Bortolotto
Tiago Bortolotto
Elene Pereira MaiaElene Pereira Maia
Elene Pereira Maia

1 November 2016 in Coordination Chemistry Reviews
Verified
Journal Article
Closed access
WGWendell Guerra
Wendell Guerra
PSPriscila Silva-Caldeira
Priscila Silva-Caldeira
HTHernán Terenzi
Hernán Terenzi
Elene Pereira MaiaElene Pereira Maia
Elene Pereira Maia

1 December 2005 in Journal of Inorganic Biochemistry
Verified
Journal Article
Closed access
WGWendell Guerra
Wendell Guerra
EAElaine de Andrade Azevedo
Elaine de Andrade Azevedo
AMAna Raquel de Souza Monteiro
Ana Raquel de Souza Monteiro
MBMônica Bucciarelli-Rodriguez
Mônica Bucciarelli-Rodriguez
ECEdmar Chartone-Souza
Edmar Chartone-Souza
Elene Pereira MaiaElene Pereira Maia
Elene Pereira Maia

1 March 2014 in Journal of Inorganic Biochemistry
Verified
Journal Article
Closed access
PSPriscila Silva-Caldeira
Priscila Silva-Caldeira
WGWendell Guerra
Wendell Guerra
GSGeandson Coelho dos Santos
Geandson Coelho dos Santos
NFNelson G. Fernandes
Nelson G. Fernandes
JSJosiane N. Silveira
Josiane N. Silveira
Elene Pereira MaiaElene Pereira Maia
Elene Pereira Maia

7 August 2023 in Molecules
Verified
Journal Article
Open access
PDF file
JRJânia dos Santos Rosário
Jânia dos Santos Rosário
FMFábio Henrique Moreira
Fábio Henrique Moreira
LRLara Hewilin Fernandes Rosa
Lara Hewilin Fernandes Rosa
WGWendell Guerra
Wendell Guerra
PSPriscila Silva-Caldeira
Priscila Silva-Caldeira
Bismuth-based drugs have been used primarily to treat ulcers caused by Helicobacter pylori and other gastrointestinal ailments. Combined with antibiotics, these drugs also possess synergistic activity, making them ideal for multiple therapy regimens and overcoming bacterial resistance. Compounds based on bismuth have a low cost, are safe for human use, and some of them are also effective against tumoral cells, leishmaniasis, fungi, and viruses. However, these compounds have limited bioavailability in physiological environments. As a result, there is a growing interest in developing new bismuth compounds and approaches to overcome this challenge. Considering the beneficial properties of bismuth and the importance of discovering new drugs, this review focused on the last decade’s updates involving bismuth compounds, especially those with potent activity and low toxicity, desirable characteristics for developing new drugs. In addition, bismuth-based compounds with dual activity were also highlighted, as well as their modes of action and structure–activity relationship, among other relevant discoveries. In this way, we hope this review provides a fertile ground for rationalizing new bismuth-based drugs.

1 March 2015 in Polyhedron
Verified
Journal Article
Closed access
JAJanaina Do Couto Almeida
Janaina Do Couto Almeida
DPDrielly A. Paixão
Drielly A. Paixão
IMIvana M. Marzano
Ivana M. Marzano
Javier Alcides EllenaJavier Alcides Ellena
Javier Alcides Ellena
Marcos PivattoMarcos Pivatto
Marcos Pivatto
WGWendell Guerra
Wendell Guerra